News

USAID is all but gone. For one family, 3 generations of service were defined by it
In a way, the requiem of the now-dismantled agency can be told through its people — including some entire families, like the ...
Eli Lilly Says Trial Patients Lost More Weight on Zepbound Than Rival’s Wegovy
The obesity drug helped patients reduce their waist size by an extra two inches compared to those on Novo Nordisk’s Wegovy in ...
Bristol Herald Courier7h
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
Our premium News+ ad-free experience – only $10 more every 4 weeks!
pharmaphorum22h
Lilly hit as PBM drops Zepbound, but retains Wegovy
Shares in Eli Lilly have weakened after CVS Health, one of the largest pharmacy benefit managers (PBMs) in the US, said it would no longer cover its obesity therapy Zepbound. The shares closed ...
pharmaphorum22h
Lilly gets first heart outcomes readout with tirzepatide
Eli Lilly's dual GLP-1/GIP agonist tirzepatide has been shown to reduce the risk of worsening disease in people with heart failure and obesity in a phase 3 trial, the first to show a benefit on ...